Medical - Devices
Compare Stocks
4 / 10Stock Comparison
VREX vs NNOX vs ATEC vs GEHC
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Devices
Medical - Devices
Medical - Healthcare Information Services
VREX vs NNOX vs ATEC vs GEHC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Medical - Devices | Medical - Devices | Medical - Devices | Medical - Healthcare Information Services |
| Market Cap | $496M | $115M | $1.17B | $27.90B |
| Revenue (TTM) | $858M | $12M | $595M | $19.95B |
| Net Income (TTM) | $-83M | $-56M | $-125M | $1.50B |
| Gross Margin | 33.6% | -98.8% | 89.6% | 42.5% |
| Operating Margin | -3.7% | -469.7% | -9.6% | 12.5% |
| Forward P/E | 11.6x | — | 24.1x | 13.0x |
| Total Debt | $402M | $7M | $620M | $10.00B |
| Cash & Equiv. | $145M | $39M | $161M | $4.51B |
VREX vs NNOX vs ATEC vs GEHC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Dec 22 | May 26 | Return |
|---|---|---|---|
| Varex Imaging Corpo… (VREX) | 100 | 48.4 | -51.6% |
| Nano-X Imaging Ltd. (NNOX) | 100 | 23.4 | -76.6% |
| Alphatec Holdings, … (ATEC) | 100 | 60.9 | -39.1% |
| GE HealthCare Techn… (GEHC) | 100 | 108.7 | +8.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: VREX vs NNOX vs ATEC vs GEHC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
VREX is the #2 pick in this set and the best alternative if value and momentum is your priority.
- Lower P/E (11.6x vs 24.1x)
- +44.8% vs NNOX's -64.4%
NNOX is the clearest fit if your priority is growth exposure and sleep-well-at-night.
- Rev growth 13.9%, EPS growth 15.7%, 3Y rev CAGR 105.3%
- Lower volatility, beta 1.86, Low D/E 3.9%, current ratio 5.63x
ATEC is the clearest fit if your priority is income & stability and long-term compounding.
- beta 1.13
- 225.4% 10Y total return vs GEHC's 2.9%
- Beta 1.13, current ratio 2.06x
- 25.0% revenue growth vs VREX's 4.1%
GEHC carries the broadest edge in this set and is the clearest fit for quality and dividends.
- 7.5% margin vs NNOX's -452.8%
- 0.2% yield; 3-year raise streak; the other 3 pay no meaningful dividend
- 4.1% ROA vs NNOX's -31.6%, ROIC 13.3% vs -27.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 25.0% revenue growth vs VREX's 4.1% | |
| Value | Lower P/E (11.6x vs 24.1x) | |
| Quality / Margins | 7.5% margin vs NNOX's -452.8% | |
| Stability / Safety | Beta 1.13 vs VREX's 1.87 | |
| Dividends | 0.2% yield; 3-year raise streak; the other 3 pay no meaningful dividend | |
| Momentum (1Y) | +44.8% vs NNOX's -64.4% | |
| Efficiency (ROA) | 4.1% ROA vs NNOX's -31.6%, ROIC 13.3% vs -27.9% |
VREX vs NNOX vs ATEC vs GEHC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
VREX vs NNOX vs ATEC vs GEHC — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
GEHC leads in 3 of 6 categories
VREX leads 0 • NNOX leads 0 • ATEC leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
GEHC leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
GEHC is the larger business by revenue, generating $20.0B annually — 1622.0x NNOX's $12M. GEHC is the more profitable business, keeping 7.5% of every revenue dollar as net income compared to NNOX's -4.5%. On growth, NNOX holds the edge at +13.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $858M | $12M | $595M | $20.0B |
| EBITDAEarnings before interest/tax | -$18M | -$46M | $4M | $3.3B |
| Net IncomeAfter-tax profit | -$83M | -$56M | -$125M | $1.5B |
| Free Cash FlowCash after capex | -$31M | -$47M | $7M | $1.5B |
| Gross MarginGross profit ÷ Revenue | +33.6% | -98.8% | +89.6% | +42.5% |
| Operating MarginEBIT ÷ Revenue | -3.7% | -4.7% | -9.6% | +12.5% |
| Net MarginNet income ÷ Revenue | -9.6% | -4.5% | -21.1% | +7.5% |
| FCF MarginFCF ÷ Revenue | -3.6% | -3.8% | +1.2% | +7.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +1.5% | +13.7% | -100.0% | +7.4% |
| EPS Growth (YoY)Latest quarter vs prior year | -2.5% | +8.7% | +37.1% | -30.9% |
Valuation Metrics
Evenly matched — VREX and GEHC each lead in 2 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, GEHC's 10.0x EV/EBITDA is more attractive than ATEC's 3752.1x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $496M | $115M | $1.2B | $27.9B |
| Enterprise ValueMkt cap + debt − cash | $753M | $83M | $1.6B | $33.4B |
| Trailing P/EPrice ÷ TTM EPS | -6.96x | -1.93x | -8.07x | 13.48x |
| Forward P/EPrice ÷ next-FY EPS est. | 11.56x | — | 24.13x | 12.95x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 20.66x |
| EV / EBITDAEnterprise value multiple | — | — | 3752.09x | 10.00x |
| Price / SalesMarket cap ÷ Revenue | 0.59x | 10.20x | 1.54x | 1.35x |
| Price / BookPrice ÷ Book value/share | 1.01x | 0.55x | 32.28x | 2.66x |
| Price / FCFMarket cap ÷ FCF | 26.38x | — | 422.56x | 18.53x |
Profitability & Efficiency
GEHC leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
GEHC delivers a 14.4% return on equity — every $100 of shareholder capital generates $14 in annual profit, vs $-4 for ATEC. NNOX carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to ATEC's 17.21x. On the Piotroski fundamental quality scale (0–9), VREX scores 6/9 vs GEHC's 4/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -17.1% | -35.5% | -4.4% | +14.4% |
| ROA (TTM)Return on assets | -7.6% | -31.6% | -15.8% | +4.1% |
| ROICReturn on invested capital | -2.6% | -27.9% | -12.6% | +13.3% |
| ROCEReturn on capital employed | -2.9% | -28.4% | -13.7% | +10.8% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 4 | 6 | 4 |
| Debt / EquityFinancial leverage | 0.83x | 0.04x | 17.21x | 0.94x |
| Net DebtTotal debt minus cash | $257M | -$32M | $459M | $5.5B |
| Cash & Equiv.Liquid assets | $145M | $39M | $161M | $4.5B |
| Total DebtShort + long-term debt | $402M | $7M | $620M | $10.0B |
| Interest CoverageEBIT ÷ Interest expense | -4.94x | -379.29x | -3.29x | 5.35x |
Total Returns (Dividends Reinvested)
GEHC leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in GEHC five years ago would be worth $10,293 today (with dividends reinvested), compared to $605 for NNOX. Over the past 12 months, VREX leads with a +44.8% total return vs NNOX's -64.4%. The 3-year compound annual growth rate (CAGR) favors GEHC at -8.0% vs NNOX's -52.4% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +1.5% | -37.8% | -62.7% | -25.9% |
| 1-Year ReturnPast 12 months | +44.8% | -64.4% | -37.8% | -10.7% |
| 3-Year ReturnCumulative with dividends | -46.3% | -89.2% | -47.8% | -22.2% |
| 5-Year ReturnCumulative with dividends | -51.8% | -93.9% | -48.7% | +2.9% |
| 10-Year ReturnCumulative with dividends | -58.0% | -96.1% | +225.4% | +2.9% |
| CAGR (3Y)Annualised 3-year return | -18.7% | -52.4% | -19.5% | -8.0% |
Risk & Volatility
Evenly matched — VREX and ATEC each lead in 1 of 2 comparable metrics.
Risk & Volatility
ATEC is the less volatile stock with a 1.13 beta — it tends to amplify market swings less than VREX's 1.87 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. VREX currently trades 81.2% from its 52-week high vs NNOX's 30.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.77x | 1.75x | 0.74x | 1.32x |
| 52-Week HighHighest price in past year | $14.56 | $5.86 | $23.29 | $89.77 |
| 52-Week LowLowest price in past year | $6.76 | $1.66 | $6.85 | $58.75 |
| % of 52W HighCurrent price vs 52-week peak | +81.2% | +30.0% | +33.3% | +68.3% |
| RSI (14)Momentum oscillator 0–100 | 56.6 | 38.5 | 26.8 | 32.1 |
| Avg Volume (50D)Average daily shares traded | 261K | 1.4M | 3.0M | 4.3M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: VREX as "Buy", NNOX as "Buy", ATEC as "Buy", GEHC as "Buy". Consensus price targets imply 922.7% upside for NNOX (target: $18) vs 22.6% for VREX (target: $15). GEHC is the only dividend payer here at 0.23% yield — a key consideration for income-focused portfolios.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $14.50 | $18.00 | $19.71 | $84.00 |
| # AnalystsCovering analysts | 6 | 5 | 18 | 18 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | +0.2% |
| Dividend StreakConsecutive years of raises | — | — | — | 3 |
| Dividend / ShareAnnual DPS | — | — | — | $0.14 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | +0.7% |
GEHC leads in 3 of 6 categories — strongest in Income & Cash Flow and Profitability & Efficiency. 2 categories are tied.
VREX vs NNOX vs ATEC vs GEHC: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is VREX or NNOX or ATEC or GEHC a better buy right now?
For growth investors, Alphatec Holdings, Inc.
(ATEC) is the stronger pick with 25. 0% revenue growth year-over-year, versus 4. 1% for Varex Imaging Corporation (VREX). GE HealthCare Technologies Inc. (GEHC) offers the better valuation at 13. 5x trailing P/E (13. 0x forward), making it the more compelling value choice. Analysts rate Varex Imaging Corporation (VREX) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — VREX or NNOX or ATEC or GEHC?
On forward P/E, Varex Imaging Corporation is actually cheaper at 11.
6x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — VREX or NNOX or ATEC or GEHC?
Over the past 5 years, GE HealthCare Technologies Inc.
(GEHC) delivered a total return of +2. 9%, compared to -93. 9% for Nano-X Imaging Ltd. (NNOX). Over 10 years, the gap is even starker: ATEC returned +215. 7% versus NNOX's -96. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — VREX or NNOX or ATEC or GEHC?
By beta (market sensitivity over 5 years), Alphatec Holdings, Inc.
(ATEC) is the lower-risk stock at 0. 74β versus Varex Imaging Corporation's 1. 77β — meaning VREX is approximately 138% more volatile than ATEC relative to the S&P 500. On balance sheet safety, Nano-X Imaging Ltd. (NNOX) carries a lower debt/equity ratio of 4% versus 17% for Alphatec Holdings, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — VREX or NNOX or ATEC or GEHC?
By revenue growth (latest reported year), Alphatec Holdings, Inc.
(ATEC) is pulling ahead at 25. 0% versus 4. 1% for Varex Imaging Corporation (VREX). On earnings-per-share growth, the picture is similar: Nano-X Imaging Ltd. grew EPS 15. 7% year-over-year, compared to -45. 3% for Varex Imaging Corporation. Over a 3-year CAGR, NNOX leads at 105. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — VREX or NNOX or ATEC or GEHC?
GE HealthCare Technologies Inc.
(GEHC) is the more profitable company, earning 10. 1% net margin versus -474. 3% for Nano-X Imaging Ltd. — meaning it keeps 10. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GEHC leads at 13. 4% versus -502. 9% for NNOX. At the gross margin level — before operating expenses — ATEC leads at 69. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is VREX or NNOX or ATEC or GEHC more undervalued right now?
On forward earnings alone, Varex Imaging Corporation (VREX) trades at 11.
6x forward P/E versus 24. 1x for Alphatec Holdings, Inc. — 12. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NNOX: 922. 7% to $18. 00.
08Which pays a better dividend — VREX or NNOX or ATEC or GEHC?
In this comparison, GEHC (0.
2% yield) pays a dividend. VREX, NNOX, ATEC do not pay a meaningful dividend and should not be held primarily for income.
09Is VREX or NNOX or ATEC or GEHC better for a retirement portfolio?
For long-horizon retirement investors, Alphatec Holdings, Inc.
(ATEC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 74), +215. 7% 10Y return). Nano-X Imaging Ltd. (NNOX) carries a higher beta of 1. 75 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ATEC: +215. 7%, NNOX: -96. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between VREX and NNOX and ATEC and GEHC?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: VREX is a small-cap quality compounder stock; NNOX is a small-cap quality compounder stock; ATEC is a small-cap high-growth stock; GEHC is a mid-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.